Status:
UNKNOWN
Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia
Lead Sponsor:
Wuhan Asia Heart Hospital
Conditions:
Heparin-Induced Thrombocytopenia
Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
Heparin induced thrombocytopenia (HIT) is a kind of catastrophic thrombotic complications after the application of heparin. If HIT without treatment, death rate is as high as 30% to 50%. Early diagnos...
Eligibility Criteria
Inclusion
- Hospitalized patients undergoing cardiac surgery.
- Receiving unfractionated heparin anticoagulation.
Exclusion
- history of heparin-induced thrombocytopenia
- pregnant woman
Key Trial Info
Start Date :
November 20 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03269019
Start Date
November 20 2017
End Date
December 31 2019
Last Update
August 31 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.